IFAM
IRON icon

Institutional & Family Asset Management’s Disc Medicine IRON Stock Holding History

Institutional & Family Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$270 Hold
6
– – ﹤0.01% 725
2024
Q1 		$374 Buy
+6
New +$389 ﹤0.01% 705

Other funds holding IRON

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Institutional & Family Asset Management's IRON Position: Q2 2024 in Review

Institutional & Family Asset Management held its Disc Medicine (IRON) position steady in Q2 2024 at 6 shares worth $270. The position accounts for ﹤0.01% of the portfolio, ranked #725.

Institutional & Family Asset Management first reported a position in IRON in Q1 2024 and has held it in 2 quarters since. The position peaked at $374 in Q1 2024. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • Institutional & Family Asset Management held 6 shares of Disc Medicine worth $270 as of Q2 2024.
  • Institutional & Family Asset Management left its Disc Medicine share count unchanged in Q2 2024.
  • Disc Medicine made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #725 holding.
  • Institutional & Family Asset Management first reported a position in Disc Medicine in Q1 2024 and has held it in 2 quarters since.
  • Institutional & Family Asset Management's Disc Medicine position peaked at $374 in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.